Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01704547 · ClinicalTrials.gov registry record
Breast Cup Immobilization Device II (GCC 1047)
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 25
- Enrollment target
NCT01704547: Completed study, sponsored by University of Maryland, Baltimore.
NCT01704547 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01704547 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The study is designed to assess the accuracy of patient breast reproducibly using the revised BCID. This study would provide data for target verification and quality assurance to eventually allow treatment of breast cancer patients for either a TBB or accelerated partial breast irradiation. The BCID is a low-risk device similar to immobilization devices used routinely in radiotherapy for other disease sites.
Primary Outcome
Complete clinical feasibility of using a breast cup immobilization device for prone breast irradiation in terms of both geometric and dosimetric accuracy. Measurements were able to be completed on 25 participants through treatment planning CT scans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-03 |
What the finished NCT01704547 record still lists
NCT01704547 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01704547 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01704547 about?
NCT01704547 is a clinical study titled "Breast Cup Immobilization Device II (GCC 1047)". The study is designed to assess the accuracy of patient breast reproducibly using the revised BCID. This study would provide data for target verification and quality assurance to eventually allow treatment of breast cancer patients for either a TBB or accelerated partial breast irradiation. The BCID...
What is the current status of trial NCT01704547?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2012-10. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT01704547?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia